chevron-down Created with Sketch Beta.
May 10, 2024

Pfizer Sued Again Over Covid-19 Vaccine Development

Even after  a recent stay of a similar suit filed by Moderna, Pfizer has again found itself the target of a lawsuit over its COVID-19 vaccine. The new suit, filed by biopharma company GSK, accuses Pfizer and BioNTech  of infringing GSK’s patents in developing their “Comirnanty”-branded COVID-19 shot.

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.